Heparin Sodium in Dextrose 5 g per 100 mL / 5000 [USP'U] per 100 mL injection

Where it's made

This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants B. Braun Medical Inc. names for other drugs.

Recalls

• May 9, 2023 · Class II · B. Braun Medical Inc
  Subpotent: Low anti-factor IIa Potency.
  Lots: Lot Number: J1P154N, Exp: 31 May, 2023,
• Mar 1, 2023 · Class II · B. Braun Medical Inc
  Subpotent Drug: low Anti-Factor IIa potency.
  Lots: Lot J2C017; Expiration: 9/30/2023.
• Jun 13, 2019 · Class II · B. Braun Medical Inc
  Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.
  Lots: Lot #: J7B259, Exp 31 Aug 2019

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Anhydrous Dextrose and Heparin: every company that makes it

Form

injection, intravenous

Strength

5 g per 100 mL / 5000 [USP'U] per 100 mL

Approval

NDA NDA019952

On the market since

Jul 20, 1992

Package NDCs

0264-9577-10

Official label

DailyMed (National Library of Medicine), updated Oct 26, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?